Singapore, Sept. 24 -- The Health Sciences Authority received information related to the study titled 'CA2400030: A Randomized, Phase 2/3 Study Comparing Navlimetostat in Combination with Nab-paclitax... Read More
Singapore, Sept. 24 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More
Singapore, Sept. 24 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837713) titled 'A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Lum... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836322) titled 'SHIFT-TB: Nutrition Intervention and Evaluation' on Sept. 14. Brief Summary: The goal of ... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836283) titled 'Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Trea... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837024) titled 'TORCH-LATAM-003: Regional Advanced-Therapy Pathways for Congenital Heart Disease' on Sept.... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837401) titled 'Factors Affecting Helicobacter Pylori Infection: Diet and Lifestyle Patterns' on Sept. 11.... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07837063) titled 'Monitoring Treatment Response With Urine and Serum Metabolome Markers in Patients Treated ... Read More
U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836257) titled 'A Phase II Study of Trastuzumab Deruxtecan (T-DXd) Plus Pyrotinib in HER2-Positive Advance... Read More